THE CLEVELAND CLINIC FOUNDATION has sponsored the creation of one or more 401k plans.
Submission information for form 5500 for 401k plan CLEVELAND CLINIC HEALTH SYSTEM PENSION TRUST
| Measure | Date | Value |
|---|
| 2022 : CLEVELAND CLINIC HEALTH SYSTEM PENSION TRUST 2022 401k financial data |
|---|
| Unrealized appreciation/depreciation of other (non real estate) assets | 2022-12-31 | $-154,539,232 |
| Total unrealized appreciation/depreciation of assets | 2022-12-31 | $-154,539,232 |
| Total transfer of assets to this plan | 2022-12-31 | $16,700,000 |
| Total transfer of assets from this plan | 2022-12-31 | $133,605,042 |
| Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities) | 2022-12-31 | $23,688,699 |
| Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities) | 2022-12-31 | $31,687,560 |
| Total income from all sources (including contributions) | 2022-12-31 | $-296,643,345 |
| Total loss/gain on sale of assets | 2022-12-31 | $-106,103,514 |
| Total of all expenses incurred | 2022-12-31 | $0 |
| Benefit payments and payments to participlants,beneficiaries,insurance carriers and others | 2022-12-31 | $0 |
| Total contributions o plan (from employers,participants, others, non cash contrinutions) | 2022-12-31 | $0 |
| Value of total assets at end of year | 2022-12-31 | $1,325,087,161 |
| Value of total assets at beginning of year | 2022-12-31 | $1,746,634,409 |
| Total of administrative expenses incurred including professional, contract, advisory and management fees | 2022-12-31 | $0 |
| Total interest from all sources | 2022-12-31 | $27,892,398 |
| Total dividends received (eg from common stock, registered investment company shares) | 2022-12-31 | $7,989,727 |
| Total dividends received from registered investment company shares (eg mutual funds) | 2022-12-31 | $7,989,727 |
| Were there any nonexempt tranactions with any party-in-interest | 2022-12-31 | No |
| Value of other receiveables (less allowance for doubtful accounts) at end of year | 2022-12-31 | $17,849,596 |
| Value of other receiveables (less allowance for doubtful accounts) at beginning of year | 2022-12-31 | $31,644,811 |
| Other liabilities (not benefit claims, operating payabales oe acquisition indebtedness) at end of year | 2022-12-31 | $23,688,699 |
| Other liabilities (not benefit claims, operating payabales oe acquisition indebtedness) at beginning of year | 2022-12-31 | $31,687,560 |
| Other income not declared elsewhere | 2022-12-31 | $5,007,039 |
| Value of net income/loss | 2022-12-31 | $-296,643,345 |
| Value of net assets at end of year (total assets less liabilities) | 2022-12-31 | $1,301,398,462 |
| Value of net assets at beginning of year (total assets less liabilities) | 2022-12-31 | $1,714,946,849 |
| Were any loans by the plan or fixed income obligations due to the plan in default | 2022-12-31 | Yes |
| Amount of loans by the plan or fixed income obligations due to the plan which were in default/classified-as-uncollectible as of the close of the plan year | 2022-12-31 | $300,000 |
| Were any leases to which the plan was party in default or uncollectible | 2022-12-31 | No |
| Assets. partnership/joint venture interests at end of year | 2022-12-31 | $218,427,195 |
| Assets. partnership/joint venture interests at beginning of year | 2022-12-31 | $265,197,040 |
| Value of interest in registered invesment companies (eg mutual funds) at end of year | 2022-12-31 | $176,014,499 |
| Value of interest in registered invesment companies (eg mutual funds) at beginning of year | 2022-12-31 | $217,970,370 |
| Interest earned on other investments | 2022-12-31 | $1,342,077 |
| Income. Interest from US Government securities | 2022-12-31 | $5,086,653 |
| Income. Interest from corporate debt instruments | 2022-12-31 | $21,414,486 |
| Value of interest in common/collective trusts at end of year | 2022-12-31 | $101,184,123 |
| Value of interest in common/collective trusts at beginning of year | 2022-12-31 | $102,184,034 |
| Value of interest bearing cash (including money market accounts and certificates of deposits) at end of year | 2022-12-31 | $50,541,304 |
| Interest-bearing cash (include money market accounts & certificates of deposit) at beginning of the Year | 2022-12-31 | $73,768,786 |
| Value of interest bearing cash (including money market accounts and certificates of deposits) at beginning of year | 2022-12-31 | $73,768,786 |
| Interest earned from interest bearing cash (including money market accounts and certificates of deposit) | 2022-12-31 | $49,182 |
| Asset value of US Government securities at end of year | 2022-12-31 | $280,378,563 |
| Asset value of US Government securities at beginning of year | 2022-12-31 | $408,055,809 |
| Net investment gain/loss from registered investment companies (e.g. mutual funds) | 2022-12-31 | $-63,985,912 |
| Net investment gain or loss from common/collective trusts | 2022-12-31 | $-12,903,851 |
| Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets | 2022-12-31 | Yes |
| Asset. Corporate debt instrument preferred debt at end of year | 2022-12-31 | $202,031,244 |
| Asset. Corporate debt instrument preferred debt at beginning of year | 2022-12-31 | $263,988,075 |
| Asset. Corporate debt instrument debt (other) at end of year | 2022-12-31 | $277,758,153 |
| Asset. Corporate debt instrument debt (other) at beginning of year | 2022-12-31 | $382,022,844 |
| Assets. Corporate common stocks other than exployer securities at end of year | 2022-12-31 | $902,484 |
| Assets. Corporate common stocks other than exployer securities at beginning of year | 2022-12-31 | $1,802,640 |
| Did the plan have assets held for investment | 2022-12-31 | Yes |
| Aggregate proceeds on sale of assets | 2022-12-31 | $2,239,970,675 |
| Aggregate carrying amount (costs) on sale of assets | 2022-12-31 | $2,346,074,189 |
| 2021 : CLEVELAND CLINIC HEALTH SYSTEM PENSION TRUST 2021 401k financial data |
|---|
| Unrealized appreciation/depreciation of other (non real estate) assets | 2021-12-31 | $-14,538,978 |
| Total unrealized appreciation/depreciation of assets | 2021-12-31 | $-14,538,978 |
| Total transfer of assets to this plan | 2021-12-31 | $758 |
| Total transfer of assets from this plan | 2021-12-31 | $144,459,401 |
| Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities) | 2021-12-31 | $31,687,560 |
| Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities) | 2021-12-31 | $19,343,874 |
| Total income from all sources (including contributions) | 2021-12-31 | $33,478,547 |
| Total loss/gain on sale of assets | 2021-12-31 | $4,489,363 |
| Total of all expenses incurred | 2021-12-31 | $0 |
| Benefit payments and payments to participlants,beneficiaries,insurance carriers and others | 2021-12-31 | $0 |
| Total contributions o plan (from employers,participants, others, non cash contrinutions) | 2021-12-31 | $0 |
| Value of total assets at end of year | 2021-12-31 | $1,746,634,409 |
| Value of total assets at beginning of year | 2021-12-31 | $1,845,270,819 |
| Total of administrative expenses incurred including professional, contract, advisory and management fees | 2021-12-31 | $0 |
| Total interest from all sources | 2021-12-31 | $18,760,350 |
| Total dividends received (eg from common stock, registered investment company shares) | 2021-12-31 | $9,963,118 |
| Total dividends received from registered investment company shares (eg mutual funds) | 2021-12-31 | $9,596,933 |
| Assets. Corporate prefeered stocks other than exployer securities at end of year | 2021-12-31 | $0 |
| Assets. Corporate prefeered stocks other than exployer securities at beginning of year | 2021-12-31 | $80,889 |
| Were there any nonexempt tranactions with any party-in-interest | 2021-12-31 | No |
| Value of other receiveables (less allowance for doubtful accounts) at end of year | 2021-12-31 | $31,644,811 |
| Value of other receiveables (less allowance for doubtful accounts) at beginning of year | 2021-12-31 | $19,697,334 |
| Other liabilities (not benefit claims, operating payabales oe acquisition indebtedness) at end of year | 2021-12-31 | $31,687,560 |
| Other liabilities (not benefit claims, operating payabales oe acquisition indebtedness) at beginning of year | 2021-12-31 | $19,343,874 |
| Other income not declared elsewhere | 2021-12-31 | $8,991,681 |
| Total non interest bearing cash at end of year | 2021-12-31 | $0 |
| Total non interest bearing cash at beginning of year | 2021-12-31 | $7,690 |
| Value of net income/loss | 2021-12-31 | $33,478,547 |
| Value of net assets at end of year (total assets less liabilities) | 2021-12-31 | $1,714,946,849 |
| Value of net assets at beginning of year (total assets less liabilities) | 2021-12-31 | $1,825,926,945 |
| Were any loans by the plan or fixed income obligations due to the plan in default | 2021-12-31 | Yes |
| Amount of loans by the plan or fixed income obligations due to the plan which were in default/classified-as-uncollectible as of the close of the plan year | 2021-12-31 | $300,000 |
| Were any leases to which the plan was party in default or uncollectible | 2021-12-31 | No |
| Assets. partnership/joint venture interests at end of year | 2021-12-31 | $265,197,040 |
| Assets. partnership/joint venture interests at beginning of year | 2021-12-31 | $341,506,773 |
| Value of interest in registered invesment companies (eg mutual funds) at end of year | 2021-12-31 | $217,970,370 |
| Value of interest in registered invesment companies (eg mutual funds) at beginning of year | 2021-12-31 | $242,817,311 |
| Interest earned on other investments | 2021-12-31 | $1,060,280 |
| Income. Interest from US Government securities | 2021-12-31 | $7,243,994 |
| Income. Interest from corporate debt instruments | 2021-12-31 | $10,457,428 |
| Value of interest in common/collective trusts at end of year | 2021-12-31 | $102,184,034 |
| Value of interest in common/collective trusts at beginning of year | 2021-12-31 | $338,481,986 |
| Value of interest bearing cash (including money market accounts and certificates of deposits) at end of year | 2021-12-31 | $73,768,786 |
| Interest-bearing cash (include money market accounts & certificates of deposit) at beginning of the Year | 2021-12-31 | $54,729,445 |
| Value of interest bearing cash (including money market accounts and certificates of deposits) at beginning of year | 2021-12-31 | $54,729,445 |
| Interest earned from interest bearing cash (including money market accounts and certificates of deposit) | 2021-12-31 | $-1,352 |
| Asset value of US Government securities at end of year | 2021-12-31 | $408,055,809 |
| Asset value of US Government securities at beginning of year | 2021-12-31 | $513,973,270 |
| Net investment gain/loss from registered investment companies (e.g. mutual funds) | 2021-12-31 | $-9,369,380 |
| Net investment gain or loss from common/collective trusts | 2021-12-31 | $15,182,393 |
| Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets | 2021-12-31 | Yes |
| Income. Dividends from common stock | 2021-12-31 | $366,185 |
| Asset. Corporate debt instrument preferred debt at end of year | 2021-12-31 | $263,988,075 |
| Asset. Corporate debt instrument preferred debt at beginning of year | 2021-12-31 | $130,897,582 |
| Asset. Corporate debt instrument debt (other) at end of year | 2021-12-31 | $382,022,844 |
| Asset. Corporate debt instrument debt (other) at beginning of year | 2021-12-31 | $163,295,904 |
| Assets. Corporate common stocks other than exployer securities at end of year | 2021-12-31 | $1,802,640 |
| Assets. Corporate common stocks other than exployer securities at beginning of year | 2021-12-31 | $39,782,635 |
| Did the plan have assets held for investment | 2021-12-31 | Yes |
| Aggregate proceeds on sale of assets | 2021-12-31 | $2,442,289,721 |
| Aggregate carrying amount (costs) on sale of assets | 2021-12-31 | $2,437,800,358 |
| 2020 : CLEVELAND CLINIC HEALTH SYSTEM PENSION TRUST 2020 401k financial data |
|---|
| Unrealized appreciation/depreciation of other (non real estate) assets | 2020-12-31 | $86,300,677 |
| Total unrealized appreciation/depreciation of assets | 2020-12-31 | $86,300,677 |
| Total transfer of assets to this plan | 2020-12-31 | $1,691,604,226 |
| Total transfer of assets from this plan | 2020-12-31 | $134,398,889 |
| Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities) | 2020-12-31 | $19,343,874 |
| Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities) | 2020-12-31 | $0 |
| Total income from all sources (including contributions) | 2020-12-31 | $268,721,608 |
| Total loss/gain on sale of assets | 2020-12-31 | $107,091,060 |
| Total of all expenses incurred | 2020-12-31 | $0 |
| Benefit payments and payments to participlants,beneficiaries,insurance carriers and others | 2020-12-31 | $0 |
| Total contributions o plan (from employers,participants, others, non cash contrinutions) | 2020-12-31 | $0 |
| Value of total assets at end of year | 2020-12-31 | $1,845,270,819 |
| Value of total assets at beginning of year | 2020-12-31 | $0 |
| Total of administrative expenses incurred including professional, contract, advisory and management fees | 2020-12-31 | $0 |
| Total interest from all sources | 2020-12-31 | $14,245,798 |
| Total dividends received (eg from common stock, registered investment company shares) | 2020-12-31 | $10,473,450 |
| Total dividends received from registered investment company shares (eg mutual funds) | 2020-12-31 | $9,811,973 |
| Assets. Corporate prefeered stocks other than exployer securities at end of year | 2020-12-31 | $80,889 |
| Assets. Corporate prefeered stocks other than exployer securities at beginning of year | 2020-12-31 | $0 |
| Were there any nonexempt tranactions with any party-in-interest | 2020-12-31 | No |
| Value of other receiveables (less allowance for doubtful accounts) at end of year | 2020-12-31 | $19,697,334 |
| Value of other receiveables (less allowance for doubtful accounts) at beginning of year | 2020-12-31 | $0 |
| Other liabilities (not benefit claims, operating payabales oe acquisition indebtedness) at end of year | 2020-12-31 | $19,343,874 |
| Other liabilities (not benefit claims, operating payabales oe acquisition indebtedness) at beginning of year | 2020-12-31 | $0 |
| Other income not declared elsewhere | 2020-12-31 | $10,578,305 |
| Total non interest bearing cash at end of year | 2020-12-31 | $7,690 |
| Total non interest bearing cash at beginning of year | 2020-12-31 | $0 |
| Value of net income/loss | 2020-12-31 | $268,721,608 |
| Value of net assets at end of year (total assets less liabilities) | 2020-12-31 | $1,825,926,945 |
| Value of net assets at beginning of year (total assets less liabilities) | 2020-12-31 | $0 |
| Were any loans by the plan or fixed income obligations due to the plan in default | 2020-12-31 | Yes |
| Amount of loans by the plan or fixed income obligations due to the plan which were in default/classified-as-uncollectible as of the close of the plan year | 2020-12-31 | $300,000 |
| Were any leases to which the plan was party in default or uncollectible | 2020-12-31 | No |
| Assets. partnership/joint venture interests at end of year | 2020-12-31 | $341,506,773 |
| Assets. partnership/joint venture interests at beginning of year | 2020-12-31 | $0 |
| Value of interest in registered invesment companies (eg mutual funds) at end of year | 2020-12-31 | $242,817,311 |
| Value of interest in registered invesment companies (eg mutual funds) at beginning of year | 2020-12-31 | $0 |
| Interest earned on other investments | 2020-12-31 | $674,664 |
| Income. Interest from US Government securities | 2020-12-31 | $5,155,708 |
| Income. Interest from corporate debt instruments | 2020-12-31 | $8,364,177 |
| Value of interest in common/collective trusts at end of year | 2020-12-31 | $338,481,986 |
| Value of interest in common/collective trusts at beginning of year | 2020-12-31 | $0 |
| Value of interest bearing cash (including money market accounts and certificates of deposits) at end of year | 2020-12-31 | $54,729,445 |
| Interest-bearing cash (include money market accounts & certificates of deposit) at beginning of the Year | 2020-12-31 | $0 |
| Value of interest bearing cash (including money market accounts and certificates of deposits) at beginning of year | 2020-12-31 | $0 |
| Interest earned from interest bearing cash (including money market accounts and certificates of deposit) | 2020-12-31 | $51,249 |
| Asset value of US Government securities at end of year | 2020-12-31 | $513,973,270 |
| Asset value of US Government securities at beginning of year | 2020-12-31 | $0 |
| Net investment gain/loss from registered investment companies (e.g. mutual funds) | 2020-12-31 | $18,906,392 |
| Net investment gain or loss from common/collective trusts | 2020-12-31 | $21,125,926 |
| Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets | 2020-12-31 | Yes |
| Income. Dividends from preferred stock | 2020-12-31 | $986 |
| Income. Dividends from common stock | 2020-12-31 | $660,491 |
| Asset. Corporate debt instrument preferred debt at end of year | 2020-12-31 | $130,897,582 |
| Asset. Corporate debt instrument debt (other) at end of year | 2020-12-31 | $163,295,904 |
| Asset. Corporate debt instrument debt (other) at beginning of year | 2020-12-31 | $0 |
| Assets. Corporate common stocks other than exployer securities at end of year | 2020-12-31 | $39,782,635 |
| Assets. Corporate common stocks other than exployer securities at beginning of year | 2020-12-31 | $0 |
| Did the plan have assets held for investment | 2020-12-31 | Yes |
| Aggregate proceeds on sale of assets | 2020-12-31 | $1,490,120,237 |
| Aggregate carrying amount (costs) on sale of assets | 2020-12-31 | $1,383,029,177 |
